Retatrutide has emerged as a new medication in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By activating these receptors, Retatrutide suppresses appetite, {promotesinsulin secretion, and ultimately results in significant slimming. While further